Press "esc" to clear
Go to Advanced Search

Showing results

110 of 593

Article ID: 700773

What Patients Don't Know (but Should) About Prostate Cancer

University of California, Los Angeles (UCLA), Health Sciences

This Prostate Cancer Awareness Week, urologist shares three things patients are surprised to learn

19-Sep-2018 10:05 AM EDT

Article ID: 700725

Researchers find adult stem cell characteristics in aggressive cancers from different tissues

University of California, Los Angeles (UCLA), Health Sciences

UCLA researchers have discovered genetic similarities between the adult stem cells responsible for maintaining and repairing epithelial tissues — which line all of the organs and cavities inside the body — and the cells that drive aggressive epithelial cancers. Their findings could bring about a better understanding of how aggressive, treatment-resistant cancers develop and progress, and could eventually lead to new drugs for a range of advanced epithelial cancers such as lung, prostate and bladder cancers.

18-Sep-2018 12:05 PM EDT
  • Embargo expired:
    13-Sep-2018 11:00 AM EDT

Article ID: 700488

Prostate Cancer Care for Older Men Estimated to Cost Medicare $1.2B

University of North Carolina Health Care System

Researchers examined the costs associated with screening for prostate cancer, including treatment, for three years after diagnosis. They estimated that for men diagnosed in each of 2004, 2005, 2006, and 2007, the total cost for treating and screening for each group would be $1.2 billion for three years after diagnosis.

13-Sep-2018 11:05 AM EDT

Article ID: 700473

Prostate Cancer PSA Screening: Finding Clarity in Confusion

Rutgers Cancer Institute of New Jersey

With recent changes in recommendations for PSA testing for prostate cancer, confusion may exist for those considering the screening. A Rutgers Cancer Institute of New Jersey expert shares what one needs to know when discussing the topic with his doctor.

13-Sep-2018 8:05 AM EDT

Article ID: 700457

With STDs at an all-time high, why aren’t more people getting a proven treatment? U-M team examines reasons

Michigan Medicine - University of Michigan

Nearly 2.3 million times last year, Americans learned they had a sexually transmitted disease. But despite these record-high infection rates for chlamydia and gonorrhea, most patients only receive treatment for their own infection – when they probably could get antibiotics or a prescription for their partner at the same time. A team of physicians examines the barriers that stand in the way of getting expedited partner therapy to more people.

12-Sep-2018 7:05 PM EDT

Article ID: 700078

Roswell Park Team Identifies Possible Cause of Resistance to Prostate Cancer Treatment

Roswell Park Comprehensive Cancer Center

A Roswell Park-led research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor expression in prostate cancer cells, identifying a new therapeutic target. Their findings were published in the journal Nature Communications.

6-Sep-2018 8:05 AM EDT

Article ID: 699970

Hormone Therapy Can Make Prostate Cancer Worse, Study Finds


Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing the cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur.

4-Sep-2018 4:45 PM EDT

Showing results

110 of 593

Chat now!